CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-13 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Baltzell Joshua J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Kong Garheng Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-05 | Haut Donald Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2017-05-16 | GILL DAVID N Director | Purchase | +3,000 | $1.68 | $5K | 11,000 |
| 2017-02-14 | Matthews Gloria Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2017-02-14 | Gridley Adam See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2017-02-14 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2017-02-14 | Kennedy Stephen Richard Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2016-12-16 | Gridley Adam See Remarks | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2016-12-16 | Baltzell Joshua J Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-16 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-16 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-16 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-16 | Kong Garheng Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-16 | RAKIN KEVIN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-15 | GILL DAVID N Director | Purchase | +3,000 | $1.65 | $5K | 8,000 |
| 2016-12-13 | SPLIT ROCK PARTNERS II, LP 10% owner | Conversion | +1,114,043 | 2,775,538 | ||
| 2016-12-13 | SPLIT ROCK PARTNERS II, LP 10% owner | Conversion · Series A Convertible Preferred Stock | −2,506.6 | 0 |
Page 21 of 27 · 525 trades